SF Healthcare Week: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year
BiotechTV - News
00:00
Handling speculation and M&A pressure
Marc explains the company stays focused on development amid takeover rumors and market pressure.
Play episode from 01:32
Transcript
